ADPGK Antibodies

Santa Cruz Biotechnology features a diverse variety of ADPGK Antibodies for research focused on understanding ADPGK's role in cellular processes. ADPGK Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ADPGK, or adenosine diphosphate-dependent glucokinase, plays a crucial role in glucose metabolism and energy homeostasis. By catalyzing the phosphorylation of glucose, ADPGK is essential for the regulation of glucose levels in cells, impacting various metabolic pathways. Understanding ADPGK function is vital for elucidating its involvement in metabolic disorders and potential therapeutic targets. Research has shown ADPGK to be particularly active in rapidly proliferating cells, suggesting its importance in cancer metabolism. Recent studies have highlighted ADPGK's potential as a therapeutic target in various disease states. Ongoing investigations continue to reveal new aspects of ADPGK's biological significance. Santa Cruz Biotechnology monoclonal antibodies for ADPGK support researchers worldwide in advancing our understanding of cellular metabolism and disease mechanisms.